Latest news

Filter by
Date
Sep 11, 2017 08:51 AM

Vale Connie Johnson OAM

Vale Constance (Connie) Johnson OAM 1977 – 2017.

MEDIA RELEASE: Sep 10, 2017 07:30 AM

Type 1 diabetes: Releasing the 'insulin handbrake' could mak...

A Garvan-led research team has shown that a new therapeutic approach can enhance insulin secretion by the pancreas, and has the potential to improve islet cell transplants in individuals with type 1 diabetes

MEDIA RELEASE: Sep 07, 2017 10:48 PM

‘Partner in crime’ mutations work together to kickstart lymp...

Australian researchers have uncovered ‘extraordinary cooperation’ between two DNA mutations that are often found together in lymphomas and leukaemias. The findings help us understand how immune cells can ‘go rogue’, beha...

Sep 06, 2017 10:50 AM

Osteoporosis: major study identifies 150 new genetic sites t...

In the largest ever study of its kind, an international research team has identified over 150 new sites in the human genome that are linked to low bone mineral density and to an increased risk of fracture. The findings v...

Aug 31, 2017 01:20 PM

Professor Mark Febbraio: exercise is medicine

Garvan congratulates Professor Mark Febbraio, who has won the 2017 Australian Diabetes Society (ADS) Kellion Award. The award recognises an Australian researcher who has made an outstanding contribution to diabetes resea...

MEDIA RELEASE: Aug 23, 2017 06:00 AM

Ground-breaking trial brings personalised treatments to thos...

Garvan's Genomic Cancer Medicine Program, launched today by The Hon. Brad Hazzard, uses genomic medicine to match therapies, prevention and screening methods with rare cancer patients based on their genetic information.

Aug 16, 2017 07:09 AM

Rare Cancers Australia sets new agenda for change

Garvan is proud to support Rare Solutions: A Time to Act, a new report released by Rare Cancers Australia that sets out a roadmap for change in the treatment and care of patients with rare cancer in Australia.

MEDIA RELEASE: Aug 04, 2017 01:00 AM

Top-to-toe MRI screen picks up early-stage cancers while sti...

A major study shows that whole-body MRI screening can identify previously undetected primary tumours throughout the body in people with high genetic risk of cancer.

Jul 27, 2017 03:29 PM

Garvan reaches 15,000 genomes

Garvan has now sequenced more than 15,000 whole genomes, a major milestone for the Kinghorn Centre for Clinical Genomics (KCCG) and Garvan’s wholly owned subsidiary, Genome.One.

Jul 14, 2017 11:30 AM

Immunotherapy – changing the way we think about cancer treat...

Garvan scientists are looking beyond their specialty areas and taking an inter-disciplinary approach that is changing the way we think about the treatment of cancer.

MEDIA RELEASE: Jul 14, 2017 04:00 AM

We inherit more than DNA: the extra blueprint layer we can’t...

An international study has provided compelling evidence that we inherit more than a DNA blueprint from our mothers and fathers – we also inherit vital instructions on how to use that blueprint.

Jul 07, 2017 11:10 AM

Interleukin-2: releasing an immune system brake to attack tu...

Researchers from Garvan’s Immunology Division have been exploring ways to make interleukin-2 immunotherapy less toxic and more effective against cancer. In doing so, the team has uncovered surprising new information abou...

MEDIA RELEASE: Jun 30, 2017 05:00 AM

Promising new therapeutic approach rebuilds and strengthens ...

Garvan researchers demonstrate that a new therapeutic approach increases bone strength and resistance to fractures in multiple myeloma bone disease

MEDIA RELEASE: Jun 20, 2017 12:00 AM

Genome.One news: Australia’s first whole genome and health ...

Genome.One has today launched Australia's first clinical service that combines whole genome sequencing with a comprehensive health assessment to enable a more precise approach to managing health.

Jun 19, 2017 10:39 PM

Garvan joins the EMBL Australia family

Garvan is to become a member of the EMBL Australia Partner Laboratory Network. The news was announced at Garvan this month during the first EMBL Alumni event to be held in Australia.

Jun 16, 2017 09:00 PM

When one becomes two: an intricate new roadmap for cell divi...

Dr Andrew Burgess and Professor Sean O’Donoghue have brought Garvan and CSIRO researchers and biodata visualisation specialists together to produce an interactive graphical representation of how a cell divides.

May 19, 2017 11:30 AM

What is personalised medicine?

Garvan explains personalised medicine.

MEDIA RELEASE: May 16, 2017 10:42 PM

Tumour-trained T cells go on patrol

‘Tumour-trained’ immune cells – which have the potential to kill cancer cells – have been seen moving from one tumour to another for the first time. The new findings, which were uncovered by scientists at Sydney’s Garvan...

May 11, 2017 02:52 PM

Love Your Sister's Big Heart Project raises over $2 million ...

History was made in Canberra yesterday, when the Big Heart Project, an initiative of Love Your Sister, raised a remarkable $2.2 million for cancer research at Garvan.

MEDIA RELEASE: May 11, 2017 12:05 AM

Proteins on the loose in a debilitating childhood disease

Australian scientists have shown, for the first time, that a family of untethered proteins builds up in the cells of children with a rare and serious genetic condition, known as mevalonate kinase deficiency (MKD).

May 05, 2017 11:00 AM

The path to understanding Parkinson’s disease

Ask any navigator: to get anywhere, it helps to consult a map. And if you don’t have a map, make one.